Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4291948
Max Phase: Preclinical
Molecular Formula: C46H74N14O18
Molecular Weight: 1111.18
Molecule Type: Small molecule
Associated Items:
ID: ALA4291948
Max Phase: Preclinical
Molecular Formula: C46H74N14O18
Molecular Weight: 1111.18
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(N)=O
Standard InChI: InChI=1S/C46H74N14O18/c1-21(2)12-27(38(49)70)55-42(74)29(14-24-18-50-20-51-24)57-45(77)32(17-37(68)69)59-46(78)33(19-61)60-41(73)28(13-22(3)4)56-40(72)26(9-10-35(64)65)54-43(75)30(15-34(48)63)58-39(71)25(8-6-7-11-47)53-44(76)31(16-36(66)67)52-23(5)62/h18,20-22,25-33,61H,6-17,19,47H2,1-5H3,(H2,48,63)(H2,49,70)(H,50,51)(H,52,62)(H,53,76)(H,54,75)(H,55,74)(H,56,72)(H,57,77)(H,58,71)(H,59,78)(H,60,73)(H,64,65)(H,66,67)(H,68,69)/t25-,26-,27-,28-,29-,30-,31-,32-,33-/m0/s1
Standard InChI Key: BRUQLWZJKDEJBD-MBZPSOJASA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1111.18 | Molecular Weight (Monoisotopic): 1110.5306 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Ran X, Burchfiel ET, Dong B, Rettko NJ, Dunyak BM, Shao H, Thiele DJ, Gestwicki JE.. (2018) Rational design and screening of peptide-based inhibitors of heat shock factor 1 (HSF1)., 26 (19): [PMID:29661622] [10.1016/j.bmc.2018.04.018] |
Source(1):